Skip to main content
. 2025 Apr 1;16:1529528. doi: 10.3389/fphar.2025.1529528

TABLE 2.

Descriptive statistics of age, BMI, and HbA1c for participants prescribed Gliflozin during the study period (n = 85).

Variable Mean (±SD) Median Min. Max. N
Age (years) 60.2 (12.0) 61 27 87 85
Body mass index (BMI) 31.7 (7.7) 30.5 16.2 62.7 85
HbA1c (%) 7.6 (1.5) 7.4 5.1 11.8 66